Nature Biotechnology
18, IT3 - IT4 (2000)
doi:10.1038/80065
Business models in biotechStelios Papadopoulos
Stelios Papadopoulos is managing director, SG Cowen
, New York. Companies with technology platforms that address only a tiny part
of the drug discovery process risk becoming optional or redundant accessories.
|
